Literature DB >> 6433575

Non-specific polyclonal antibody response induced by Mycoplasma pneumoniae.

G Biberfeld, P Arneborn, M Forsgren, L V von Stedingk, S Blomqvist.   

Abstract

The ability of heat-killed Mycoplasma pneumoniae (MP) organisms to induce polyclonal antibody production in cultures of blood lymphocytes of healthy subjects was studied. MP induced both IgM and IgG production, with a predominance of IgM. Supernatants of MP-stimulated lymphocyte cultures were tested by an enzyme-linked immunosorbent assay for antibodies to measles, rubella, and herpes simplex virus. MP as well as pokeweed mitogen induced production of viral antibodies of IgG class in lymphocytes of donors who had serum antibodies to the corresponding viral antigens. The MP-induced non-specific antibody response was T-cell-dependent. Lymphocytes from four patients with MP pneumonia, collected nine to 13 days after onset of illness, were tested for in vitro Ig production in the absence of MP. These lymphocytes spontaneously produced increased amounts of IgM and/or IgG. Lymphocytes from three of these four patients spontaneously produced viral IgG antibodies to measles and/or varicella antigens, indicating that MP had induced non-specific activation of memory B cells in vivo. Spontaneous viral antibody production was not found in lymphocyte cultures of healthy donors. The non-specific activation of blood B cells in vitro is probably induced by non-specific helper factors from MP-activated T cells. It is possible that in vivo MP also may have a direct activating effect on B cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6433575      PMCID: PMC2590507     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  6 in total

1.  Mycoplasma pneumoniae is a polyclonal B-cell activator.

Authors:  G Biberfeld; E Gronowicz
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

2.  PPD-induced viral antibody production in human blood lymphocytes.

Authors:  G Biberfeld; M Forsgren; L V Von Stedingk; P Arneborn
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

Review 3.  Regulation of human B cell activation.

Authors:  R S Geha
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 4.  Hypothesis: nonspecific polyclonal activation of memory B cells by antigen as a mechanism for the preservation of long term immunologic anamnesis.

Authors:  E J Moticka; J W Streilein
Journal:  Cell Immunol       Date:  1978-12       Impact factor: 4.868

5.  Specific and non-specific B cell activation in measles and varicella.

Authors:  P Arneborn; G Biberfeld; M Forsgren; L V von Stedingk
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

6.  Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae.

Authors:  G Biberfeld
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

  6 in total
  7 in total

1.  Post-infectious encephalomyelitis associated with Mycoplasma pneumoniae and Legionella pneumophila infection.

Authors:  P J Easterbrook; E G Smyth
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

2.  Number of specific antibody-secreting cells in the peripheral blood among children with mycoplasma pneumonia.

Authors:  M Iseki; T Takahashi; K Kimura; R Yamashita; T Sasaki
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Primary antibody responses to thymus-independent antigens in the lungs and hilar lymph nodes of mice.

Authors:  S N Goud; A M Kaplan; B Subbarao
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.

Authors:  Abdouramane Traoré; Merepen A Guindo; Drissa Konaté; Bourama Traoré; Seidina A Diakité; Salimata Kanté; Assitan Dembélé; Abdourhamane Cissé; Nathan C Incandela; Mamoudou Kodio; Yaya I Coulibaly; Ousmane Faye; Andrey V Kajava; Federico Pratesi; Paola Migliorini; Anna Maria Papini; Lorenzo Pacini; Paolo Rovero; Fosca Errante; Mahamadou Diakité; Myriam Arevalo-Herrera; Socrates Herrera; Giampietro Corradin; Saidou Balam
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

5.  Binding of thyrotropin to selected Mycoplasma species: detection of serum antibodies against a specific Mycoplasma membrane antigen in patients with autoimmune thyroid disease.

Authors:  J Sack; D Zilberstein; M F Barile; Y G Lukes; J R Baker; L Wartofsky; K D Burman
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

Review 6.  Manifestations and complications of Mycoplasma pneumoniae disease: a review.

Authors:  K Lind
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec

7.  Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent.

Authors:  Yasemin Topcu; Erhan Bayram; Pakize Karaoglu; Uluc Yis; Handan Guleryuz; Semra Hiz Kurul
Journal:  J Pediatr Neurosci       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.